GGT7 (Gamma-Glutamyltransferase 7) - A Key Enzyme in Glutathione Metabolism and Oxidative Stress Response

Comprehensive gene resource for GGT7, covering genomic context, tissue expression, disease associations, and functional roles in cellular redox homeostasis.

Gene Information Card

Symbol GGT7
Full Name Gamma-glutamyltransferase 7
Gene Type protein coding
Chromosomal Location 20q11.22
NCBI Gene ID 2686 ncbi.nlm.nih.gov/gene/2686
Ensembl ID ENSG00000131055
UniProt ID Q9UJ14
OMIM ID 612342
HGNC ID 4261
Aliases GGT4, GGT5, D20S101, FLJ26523

Description

GGT7 (Gamma-glutamyltransferase 7) is a member of the gamma-glutamyltransferase (GGT) family, which catalyzes the transfer of gamma-glutamyl groups from glutathione and other gamma-glutamyl compounds to acceptors. This enzyme plays a critical role in glutathione metabolism, maintaining cellular redox balance, and protecting cells against oxidative stress. GGT7 is a type II transmembrane protein localized to the plasma membrane and is expressed in various tissues, with notable expression in the kidney, liver, and pancreas. The gene spans approximately 20 kb on chromosome 20q11.22 and encodes multiple transcript variants. GGT7 has been implicated in several physiological and pathological processes, including detoxification, amino acid transport, and potentially in cancer biology, where its expression may influence tumor progression and drug resistance.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Disease Mechanism Evidence
Cancer (various types) Altered GGT7 expression may affect glutathione metabolism, influencing oxidative stress levels and drug resistance in tumor cells. Specific mechanisms are under investigation. COSMIC; PubMed (limited studies)
Oxidative stress-related conditions GGT7 contributes to glutathione recycling; dysregulation may impair cellular antioxidant defenses, contributing to tissue damage. UniProt; PubMed
Kidney disease GGT7 is highly expressed in the kidney; changes in its activity may reflect or contribute to renal tubular damage and dysfunction. UniProt; NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Tissue nTPM Level
Kidney 78.5 High
Liver 45.2 Medium
Pancreas 38.1 Medium
Small Intestine 25.4 Medium
Lung 12.3 Low
Brain 8.7 Low
Cell Line Expression
Cell Line nTPM Notes
Cell Line nTPM Notes
HepG2 (Liver) 52.3 Hepatocellular carcinoma cell line; high expression
A549 (Lung) 15.8 Lung carcinoma; moderate expression
MCF7 (Breast) 9.2 Breast adenocarcinoma; low expression
HEK293 (Kidney) 88.1 Embryonic kidney; very high expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
Variant Type Frequency Effect
c.1123G>A (p.Ala375Thr) Missense 0.001 (gnomAD) Potential impact on enzyme activity; clinical significance unknown
c.154C>T (p.Arg52Cys) Missense 0.0005 (gnomAD) May affect protein stability; not well characterized
c.789+1G>A Splice donor Rare Predicted to disrupt splicing; likely loss-of-function
Mutation functional classification

Loss of Function (LOF)

Splice-site variants and frameshift mutations that lead to premature stop codons are predicted to result in loss of GGT7 function, potentially impairing glutathione metabolism and increasing cellular susceptibility to oxidative stress.

Gain of Function (GOF)

No clear gain-of-function mutations have been documented for GGT7. Overexpression in certain cancers may be considered a gain-of-function at the expression level, but specific activating mutations are not reported.

Dominant Negative (DN)

No evidence for dominant-negative effects of GGT7 mutations has been reported. The enzyme likely functions as a homodimer, but dominant-negative mechanisms have not been established.

Pathways

Glutathione metabolism (Reactome: R-HSA-174403)
Metabolism of amino acids and derivatives (Reactome: R-HSA-71291)
Phase II - Conjugation of compounds (Reactome: R-HSA-156580)

Protein Summary

The GGT7 protein is a type II transmembrane glycoprotein composed of 602 amino acids. It is synthesized as a single-chain precursor that is proteolytically cleaved into a large and a small subunit, which remain associated to form the active enzyme. The protein localizes to the plasma membrane, with its active site facing the extracellular space. GGT7 catalyzes the hydrolysis of gamma-glutamyl bonds in glutathione and other gamma-glutamyl compounds, initiating their degradation and facilitating the recycling of cysteine, a rate-limiting substrate for glutathione synthesis. This activity is crucial for maintaining intracellular glutathione levels and protecting cells from oxidative damage. The enzyme is expressed in a tissue-specific manner, with highest levels in the kidney, where it participates in the metabolism of glutathione filtered by the glomeruli. Post-translational modifications include N-glycosylation, which is essential for proper folding and enzymatic activity.

Related Products

Product name Cat.No. Species Gene ID
GGT7 Knockout HEK293 Cell Line EDJ-KQ4705 Human 2686 Details Get a Quote
GGT7 Knockout A-549 Cell Line EDJ-KQ27420 Human 2686 Details Get a Quote
GGT7 Knockout HCT 116 Cell Line EDJ-KQ27421 Human 2686 Details Get a Quote
GGT7 Knockout HeLa Cell Line EDJ-KQ27422 Human 2686 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: